suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

Objectives: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing the cut-offs ⩽4, 4-6, and ⩾6 ng/mL) with risk of 14-day mortality, and with the risk of mechani...

Full description

Bibliographic Details
Main Authors: Izzet Altintas, Jesper Eugen-Olsen, Santeri Seppälä, Jens Tingleff, Marius Ahm Stauning, Nora Olsen El Caidi, Sanaá Elmajdoubi, Hejdi Gamst-Jensen, Mette B Lindstrøm, Line Jee Hartmann Rasmussen, Klaus Tjelle Kristiansen, Christian Rasmussen, Jan O Nehlin, Thomas Kallemose, Harri Hyppölä, Ove Andersen
Format: Article
Language:English
Published: SAGE Publishing 2021-08-01
Series:Biomarker Insights
Online Access:https://doi.org/10.1177/11772719211034685

Internet

https://doi.org/10.1177/11772719211034685

Similar Items